Concepedia

Herbert R. Roth

HR

4

Publications

150

Citations

4

H-Index

1962

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Herbert R. Roth is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and organic chemistry.

Top concepts

PharmacologyMedicinal ChemistryMedicineEngineeringDrug DiscoveryNatural SciencesOrganic ChemistryAnalytical ChemistryChemistryBiochemistry

Publications per year

1962–1992

4

Publications

4

Diethyl 2,4-dioxoimidazolidine-5-phosphonates: Horner-Wadsworth-Emmons reagents for the mild and efficient preparation of C-5 unsaturated hydantoin derivatives

Nicholas A. Meanwell, Herbert R. Roth, Edward C. Smith et al. · The Journal of Organic Chemistry · 1991 · 68 citations

Medicinal Chemistry, Derivative (Chemistry), Bioorganic Chemistry +13

Sulfonanilides. II. Analogs of Catecholamines

A. A. Larsen, William A. Gould, Herbert R. Roth et al. · Journal of Medicinal Chemistry · 1967 · 41 citations

Therapeutic Drug Monitoring, Medicinal Chemistry, Pharmacological Study +11

Pyrrolidines. VII. 3-Hydroxy-1-Pyrrolidinecarboxylic Acid Esters

Yaohua Wu, William A. Gould, Walter G. Lobeck et al. · Journal of Medicinal Chemistry · 1962 · 22 citations

Medicinal Chemistry, Derivative (Chemistry), Engineering +14

Inhibitors of blood platelet cAMP phosphodiesterase. 2. Structure-activity relationships associated with 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones substituted with functionalized side chains

Nicholas A. Meanwell, Bradley C. Pearce, Herbert R. Roth et al. · Journal of Medicinal Chemistry · 1992 · 19 citations · Full text

Rows per page

1–4 of 4